All Posts Tagged With: "merck"
Profits Before People: Merck and Schering-Plough Caught Red handed
Emails between a Schering-Plough executive and the principle investigator of the ENHANCE trial were made public today by Sen. Chuck Grassley. The emails reveal that the ENHANCE trial’s principal investigator perceived that the drugmakers were withholding unfavorable results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons. (Surprise Surprise). Instead of releasing the bad data, Sen. Grassley noted, [...]
Popularity: 64% [?]
1Apr2008 | PharmaWatchDog | 0 comments | Continued
Merck and Schering-Plough Continue to Feel the Heat
A House committee implied today that Merck and Schering-Plough were aware months before they issued preliminary results of the ENHANCE study in a press release that the trial was negative.
The committee made public several anonymous emails posted on an industry chat site suggesting knowledge up to nine months before release of the preliminary data [...]
Popularity: 53% [?]
15Feb2008 | PharmaWatchDog | 1 comment | Continued
Federal Grand Jury Probes Merck’s Handling of Vioxx
Merck & Co. is the subject of a federal grand-jury probe into its sales and marketing practices for Vioxx, the painkiller it pulled from the market in 2004, according to a person familiar with the matter.
The health-care-fraud unit of the U.S. Attorney’s Office for the District of Massachusetts is investigating whether Merck promoted Vioxx to [...]
Popularity: 47% [?]
4Feb2008 | PharmaWatchDog | 1 comment | Continued
Challenge filed to Merck’s Vioxx settlement
Lawyers for hundreds of people who sued Merck & Co. over its withdrawn painkiller Vioxx are challenging a key provision of a proposed $4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal.Plaintiffs lawyers who negotiated the settlement said Friday they expect the challenge will be withdrawn, [...]
Popularity: 32% [?]
5Jan2008 | PharmaWatchDog | 1 comment | Continued
